Skip to content


BMC Pharmacology and Toxicology

Featured article: Preventing angiogenesis inhibits oral cancer growth

Angiogenesis, the formation of new blood vessels from preexisting vessels, is critical for oral cancer development. Semaforin-3 (Sema3) is a secreted protein that prevents angiogenesis. Overexpression of Sema3 in oral tumor cell lines decreases tumor vasculature in vitro and decreases the size and capillary density of tumors in xenograft models of oral cancer in mice.

Featured collection: Neurometals


Metals have many essential functions in the brain and a large body of evidence supports important roles for altered metal stasis in many brain disorders. This article collection guest edited by Section Editor, Dr Michael Aschner provides a node for other researchers across diverse fields to access brain metal research and integrate this into their own programs.

Read More


View all articles
View all articles

Aims and scope

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials.It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.


Section Editors

  • Michael Aschner, Albert Einstein College of Medicine
  • Phil Biggin, University of Oxford
  • Lucio Guido Costa, University of Washington
  • David H Farb, Boston University School of Medicine
  • Giorgio Palu, University of Padova
  • Catherine MT Sherwin, University of Utah

Catherine Sherwin, Section Editor

Dr. Catherine Sherwin is currently an Associate Professor

Data support service

Authors submitting to this journal can opt to use a new service that will make it easier to share research data.

Find out more

BMC Pharmacology

BMC Pharmacology and Toxicology assimilated the Editorial boards and history of BMC Pharmacology and BMC Clinical Pharmacology on fusion of the journals in 2012. The full archive of BMC Pharmacology is available from its own archive website, and the objectives and aspirations of the merged journal are explained in the editorial that accompanied the fusion. The full archive of BMC Clinical Pharmacology is available here.

Latest Tweets


2016 Journal Metrics